mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.8 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.8 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |